Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Nosocomial bloodstream infections (BSIs) are important causes of morbidity and mortality in the United States. METHODS: Data from a nationwide, concurrent surveillance study (Surveillance and Control of Pathogens of Epidemiological Importance [SCOPE]) were used to examine the secular trends in the epidemiology and microbiology of nosocomial BSIs. RESULTS: Our study detected 24,179 cases of nosocomial BSI in 49 US hospitals over a 7-year period from March 1995 through September 2002 (60 cases per 10,000 hospital admissions). Eighty-seven percent of BSIs were monomicrobial. Gram-positive organisms caused 65% of these BSIs, gram-negative organisms caused 25%, and fungi caused 9.5%. The crude mortality rate was 27%. The most-common organisms causing BSIs were coagulase-negative staphylococci (CoNS) (31% of isolates), Staphylococcus aureus (20%), enterococci (9%), and Candida species (9%). The mean interval between admission and infection was 13 days for infection with Escherichia coli, 16 days for S. aureus, 22 days for Candida species and Klebsiella species, 23 days for enterococci, and 26 days for Acinetobacter species. CoNS, Pseudomonas species, Enterobacter species, Serratia species, and Acinetobacter species were more likely to cause infections in patients in intensive care units (P<.001). In neutropenic patients, infections with Candida species, enterococci, and viridans group streptococci were significantly more common. The proportion of S. aureus isolates with methicillin resistance increased from 22% in 1995 to 57% in 2001 (P<.001, trend analysis). Vancomycin resistance was seen in 2% of Enterococcus faecalis isolates and in 60% of Enterococcus faecium isolates. CONCLUSION: In this study, one of the largest multicenter studies performed to date, we found that the proportion of nosocomial BSIs due to antibiotic-resistant organisms is increasing in US hospitals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the United States and elsewhere, Candida species are a leading cause of health care–associated bloodstream infections (3–5).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [4]
In the citing paper
“The incidence of nosocomial candidiasis has increased over the past few decades [28,29,30,31,32].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Candidaemia is the most common form of invasive candidiasis associated with an unacceptably high mortality rates in excess of 40% even with the introduction of newer antifungal agents [30,32,33].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Data from a US surveillance study found that over a 7year period Candida spp.accounted for 4.6 bloodstream infections per 10,000 admissions and 9% of all bloodstream infections [1], whereas the incidence may vary between centers.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
In the citing paper
“Among documented invasive fungal infections, candidemia and invasive candidiasis are encountered with increasing incidence in nosocomial settings [1].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[30] showed that mortality rates doubled, from 30% to 60%, when inappropriate empirical antibiotic therapy was given to ICU patients with BSIs.”
BackgroundNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387 · cited 3×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundMethodSelf-citationDiekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundWeinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228 · cited 1×
“Recent studies have shown that the proportion of contaminants is lower if 2 or more positive blood culture results (of samples drawn within a few hours of each other) were required for inclusion [9, 32, 33].”
BackgroundPittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Kreger, B. E., Craven, D. E., Carling, P. C., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90101-1 · Cited by 595 · cited 1×
“The crude rate mortality ranged from 12% in total hospital populations to 80% in ICU patients [6–10].”
BackgroundEmergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundFridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, Jr., Archibald, L. K., Gaynes, R. P., & Tenover, F. C. (1999) · Clinical Infectious Diseases · doi:10.1086/520193 · Cited by 486
Research works printed but not linked: 1
- 1996, 77, 791, 10.1002/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2-V · DOI · Paper page
Cited by
Items 501–600 of 1,033
Magill, S. S., Swoboda, S. M., Johnson, E. A., Merz, W. G., Pelz, R. K., Lipsett, P. A., & Hendrix, C. W. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.03.013 · Cited by 107
“are the 3rd most common cause of nosocomial bloodstream infections (BSIs) in the ICU and are associated with the 2nd highest crude mortality among ICU patients with monomicrobial BSI (Wisplinghoff et al., 2004).”
BackgroundVebø, H. C., Solheim, M., Snipen, L. G., Nes, I. F., & Brede, D. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012489 · Cited by 119
“enterococci now rank among the leading causes of infections among hospital patients [1,2].”
BackgroundCandida Biofilms: An Update on Developmental Mechanisms and Therapeutic Challenges
de Barros, P. P., Rossoni, R. D., de Souza, C. M., Scorzoni, L., Fenley, J. D. C., & Junqueira, J. C. (2020) · Mycopathologia · doi:10.1007/s11046-020-00445-w · Cited by 121
Population-Based Study of Bloodstream Infection Incidence and Mortality Rates, Finland, 2004–2018
Kontula, K. S. K., Skogberg, K., Ollgren, J. P., Järvinen, A., & Lyytikäinen, O. (2021) · Emerging infectious diseases · doi:10.3201/eid2710.204826 · Cited by 116
Kumar, S., Bansal, A., Chakrabarti, A., & Singhi, S. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31826a409c · Cited by 98
Deckman, J. M., Meissler, J. J., Robinson, R. H., Spence, P. B., Truant, A., Gaughan, J. P., & Eisenstein, T. K. (2011) · Infection and Immunity · doi:10.1128/iai.00069-11 · Cited by 101
Cosgaya, C., Marí-Almirall, M., Assche, A. V., Fernández‐Orth, D., Mosqueda, N., Tellı, M., Huys, G. R. B., Higgins, P. G., Seifert, H., Lievens, B., et al. (2016) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.001318 · Cited by 99
Self-citationTsuzuki, S., Matsunaga, N., Yahara, K., Gu, Y., Hayakawa, K., Hirabayashi, A., Kajihara, T., Sugai, M., Shibayama, K., & Ohmagari, N. (2019) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2019.10.017 · Cited by 103
“The number and proportion of BSIs caused by E. coli has been increasing globally [9 e 11].”
Human inborn errors of immunity underlying superficial or invasive candidiasis
Puel, A. (2020) · Human Genetics · doi:10.1007/s00439-020-02141-7 · Cited by 109
Epidemiological interpretation of antibiotic resistance studies – what are we missing?
Schwaber, M. J., De-Medina, T., & Carmeli, Y. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1047 · Cited by 113
Balkhy, H. H., Cunningham, G., Chew, F. K., Francis, C., Al-Nakhli, D. J., Almuneef, M. A., & Memish, Z. A. (2006) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2005.06.013 · Cited by 98
“Our department has, for many years, been making major efforts to reduce the magnitude of VAPs in our ICUs.”
ResultColistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections
Martis, N., Leroy, S., & Blanc, V. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.03.001 · Cited by 98
Falagas, M. E., & Karveli, E. A. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01596.x · Cited by 99
“Most of these patients have respiratory tract infections, but a minority of patients have bacteraemia with an unknown primary site [10,11].”
Kallen, A. J., Patel, P. R., & O’Grady, N. P. (2010) · Clinical Infectious Diseases · doi:10.1086/653942 · Cited by 103
“[2–4].”
Host response to Candida albicans bloodstream infection and sepsis
Duggan, S., Leonhardt, I., Hünniger, K., & Kurzai, O. (2015) · Virulence · doi:10.4161/21505594.2014.988096 · Cited by 97
“account for 8–10% of all positive blood cultures.(14,15) However, despite being a frequent cause of nosocomial infection, Candida spp.”
BackgroundImmune Sensing of Candida albicans
Bojang, E., Ghuman, H., Kumwenda, P., & Hall, R. A. (2021) · Journal of Fungi · doi:10.3390/jof7020119 · Cited by 96
Jones, C. J., Ryder, C., Mann, E. E., & Wozniak, D. J. (2013) · Journal of Bacteriology · doi:10.1128/jb.02190-12 · Cited by 116
“aeruginosa infections that can last decades (2, 3), leading to decreased lung function (4–6).”
BackgroundFolgori, L., Livadiotti, S., Carletti, M., Bielicki, J. A., Pontrelli, G., Atti, M. L. C. D., Bertaina, C., Lucignano, B., Ranno, S., Carretto, E., et al. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000339 · Cited by 98
“2%, results that are comparable with other previous data in pediatrics.(13,14,24) Consistent with previous reports,(25) in our cohort TABLE 2.”
ResultTeixeira, M. C., Viana, R., Palma, M., Oliveira, J. S., Galocha, M., Mota, M. N., Couceiro, D., Pereira, M. G., Antunes, M., Costa, I. V., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1041 · Cited by 112
“On the other end of the spectrum lay pathogenic yeasts of the Candida genus, major causative agents of human systemic fungemia, and responsible for more than 400,000 in life-threatening infections worldwide every year (8).”
BackgroundStaphylococcus , Micrococcus , and Other Catalase-Positive Cocci
Becker, K., Skov, R. L., & von Eiff, C. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch21 · Cited by 130
Rupp, M. E., Holley, H. P., Lutz, J., Dicpinigaitis, P. V., Woods, C. W., Levine, D. P., Veney, N., & Fowler, V. G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00570-07 · Cited by 96
Beibei, L., Yun, C., Mengli, C., Nan, B., Xuhong, Y., & Wang, R. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.09.013 · Cited by 97
Oh, J., Fung, E., Schlecht, U., Davis, R. W., Giaever, G., St. Onge, R. P., Deutschbauer, A., & Nislow, C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001140 · Cited by 95
“albicans alone accounts for over 50% of all fungal infections [3].”
BackgroundVale-Silva, L. A., Coste, A. T., Ischer, F., Parker, J. E., Kelly, S. L., Pinto, E., & Sanglard, D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05720-11 · Cited by 97
“represent the fourth most common cause of nosocomial bloodstream infections in the United States, while displaying the highest or second highest crude mortality rates (11, 45).”
BackgroundEsterly, J. S., Griffith, M. M., Qi, C., Malczynski, M., Postelnick, M. J., & Scheetz, M. H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01728-10 · Cited by 96
“The attributable mortality rates for patients with Acinetobacter baumannii infections seen in a large multicenter study have been estimated as 34% in all patients and 43% in patients in intensive care units (ICUs), the third highest seen for any nosocomial bloodstream pathogen in each category (34).”
BackgroundTigecycline: a novel glycylcycline antibiotic
Zhanel, G. G., Karlowsky, J. A., Rubinstein, E., & Hoban, D. J. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.1.9 · Cited by 102
Gorityala, B. K., Guchhait, G., Fernando, D. M., Deo, S. R., McKenna, S. A., Zhanel, G. G., Kumar, A., & Schweizer, F. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508330 · Cited by 96
Gabriel, A., Shores, J. T., Bernstein, B., de Leon, J., Kamepalli, R., Wolvos, T. A., Baharestani, M. M., & Gupta, S. C. (2009) · International Wound Journal · doi:10.1111/j.1742-481x.2009.00628.x · Cited by 96
Reboli, A. C., Shorr, A. F., Rotstein, C., Pappas, P. G., Kett, D. H., Schlamm, H. T., Reisman, A. L., Biswas, P., & Walsh, T. J. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-261 · Cited by 94
“albicans continues to be the most common Candida species isolated [6,11,12].”
BackgroundRole of haem oxygenase-1 in microbial host defence
Chung, S. W., Hall, S. R., & Perrella, M. A. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01261.x · Cited by 96
“It has been reported that the incidence of candidemia has increased significantly in recent years, and Candida species account for 9% of nosocomial bloodstream infections, making Candida the fourth most common cause of nosocomial bloodstream infections in the USA (Wisplinghoff et al., 2004).”
BackgroundInfluentialAnalysis of gene evolution and metabolic pathways using the Candida Gene Order Browser
Fitzpatrick, D. A., O'Gaora, P., Byrne, K. P., & Butler, G. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-290 · Cited by 93
“Candida species account for approximately 10% of all bloodstream infections [1] and worldwide are the most common cause of opportunistic fungal infection [2].”
Buchan, B. W., & Ledeboer, N. A. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03105-12 · Cited by 107
Twenty-two years of candidaemia surveillance: results from a Norwegian national study
Hesstvedt, L., Gaustad, P., Andersen, C. T., Haarr, E., Hannula, R., Haukland, H. H., Hermansen, N. O., Larssen, K. W., Mylvaganam, H., Ranheim, T. E., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.06.008 · Cited by 101
Pfaller, M. A., Bassetti, M., Duncan, L. R., & Castanheira, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx009 · Cited by 97
Risk factors for candidaemia in critically ill patients: a prospective surveillance study*
Jordà‐Marcos, R., Álvarez‐Lerma, F., Jurado, M., Palomar, M., Nolla‐Salas, J., León, M. A., León, C., & the EPCAN Study Group (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01366.x · Cited by 95
Reemergence of Gram-negative Health Care–Associated Bloodstream Infections
Albrecht, S. J., Fishman, N. O., Kitchen, J., Nachamkin, I., Bilker, W. B., Hoegg, C., Samel, C., Barbagallo, S., Arentzen, J., & Lautenbach, E. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.12.1289 · Cited by 94
“Other studies in the United States and Europe during the last 2 decades have found similar increases in BSIs due to CNS,(3,7-9) S aureus,(3) enterococci(3,10) and Candida species.(3,7,11) CME course available at www.”
BackgroundInfluentialDeterminants of mortality in non-neutropenic ICU patients with candidaemia.
Marriott, D. J., Playford, E. G., Chen, S., Slavin, M., Nguyen, Q., Ellis, D., Sorrell, T. C., & Study, T. A. C. (2009) · Critical Care · doi:10.1186/cc7964 · Cited by 93
“Introduction Candidaemia is a relatively common healthcare-associated infection in critically-ill patients in intensive care units (ICUs) [1-3] that is associated with poor clinical outcomes and excess economic costs [4,5].”
BackgroundMechanisms of Candida albicans Trafficking to the Brain
Liu, Y., Mittal, R., Solis, N. V., Prasadarao, N. V., & Filler, S. G. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002305 · Cited by 93
“that remains associated with approximately 35% mortality, even with currently available treatment, and Candida albicans is the infecting organism in approximately 50% of patients [1,2].”
BackgroundLiang, L., Goh, S. G., Vergara, G. G. R. V., Fang, H., Rezaeinejad, S., Chang, S. Y., Bayen, S., Lee, W. A., Sobsey, M. D., Rose, J. B., et al. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.02670-14 · Cited by 93
“Norovirus GII (GC/liter) 156 (60) 253 (80) 69 (47) 55 (13) 79 (40)”
Recognition of yeast nucleic acids triggers a host‐protective type I interferon response
Biondo, C., Signorino, G., Costa, A., Midiri, A., Gerace, E., Galbo, R., Bellantoni, A., Malara, A., Beninati, C., Teti, G., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141490 · Cited by 93
Binkley, S., Fishman, N. O., LaRosa, L. A., Marr, A. M., Nachamkin, I., Wordell, D. C., Bilker, W. B., & Lautenbach, E. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/505921 · Cited by 96
“Wisplinghoff et al.(13) similarly observed that, for neutropenic patients with S.”
BackgroundRecent advances in delivery of antifungal agents for therapeutic management of candidiasis
Sawant, B., & Khan, T. A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.127 · Cited by 112
The effect of time to antifungal therapy on mortality in candidemia associated septic shock
Patel, G. P., Simon, D., Scheetz, M., Crank, C. W., Lodise, T., & Patel, N. (2009) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181a1afb7 · Cited by 92
Leroy, G., Lambiotte, F., Thévenin, D., Lemaire, C., Parmentier, E., Devos, P., & Leroy, O. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-50 · Cited by 92
“Among the causes of nosocomial bloodstream infections, Candida ranks number four in the United States [2].”
BackgroundSecular trend in candidemia and the use of fluconazole in Finland, 2004-2007
Poikonen, E., Lyytikäinen, O., Anttila, V.-J., Koivula, I., Lumio, J., Kotilainen, P., Syrjälä, H., & Ruutu, P. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-312 · Cited by 93
“In the USA Candida species rank the fourth most common (7-9%) causative organism of all bloodstream infections in hospitalized patients,[6-8] but in Europe it accounts for less than 5% [9-11].”
Backgroundβ-Defensin 1 Plays a Role in Acute Mucosal Defense against Candida albicans
Tomalka, J., Azodi, E., Narra, H. P., Patel, K., O’Neill, S., Cardwell, C., Hall, B. A., Wilson, J. M., & Hise, A. G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1203239 · Cited by 94
“Infection with Candida is normally superficial and limited to mucosal surfaces; however, disseminated candidiasis can result in significant mortality (1, 2).”
BackgroundSu, C., Lu, Y., & Liu, H. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-06-0477 · Cited by 94
“Candida ranks fourth in nosocomial bloodstream infections (Wisplinghoff et al., 2004).”
Epidemiology of Candidemia at a Children's Hospital, 2002 to 2006
Neu, N., Malik, M., Lunding, A., Whittier, S., Alba, L., Kubin, C., & Saiman, L. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181a0d78d · Cited by 92
“Candida albicans remains the predominant species causing candidemia in adults, although rates of nonalbicans species, specifically Candida glabrata, have increased.(1,3,7) In some pediatric populations, the predominant species has been Candida parapsilosis.”
BackgroundRAAD, I. I., Kassar, R., Ghannam, D., Chaftari, A., Hachem, R. Y., & Jiang, Y. (2009) · Clinical Infectious Diseases · doi:10.1086/605694 · Cited by 101
“These organisms are now considered the most commonly reported pathogens to cause nosocomial bloodstream infection in hospitalized patients [4, 5].”
BackgroundNoto, M. J., Kreiswirth, B. N., Monk, A. B., & Archer, G. L. (2007) · Journal of Bacteriology · doi:10.1128/jb.01128-07 · Cited by 114
“In addition, there is considerable homology among the variants of type IV SCCmec, as well as between types IV and I SCCmec (12, 30).”
BackgroundAntifungal agents for preventing fungal infections in non-neutropenic critically ill patients
Cortegiani, A., Russotto, V., Maggiore, A., Attanasio, M., Naro, A. R., Raineri, S. M., & Giarratano, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004920.pub3 · Cited by 91
Moran, C., Grussemeyer, C. A., Spalding, J. R., Benjamin, D. K., & Reed, S. D. (2010) · American Journal of Infection Control · doi:10.1016/j.ajic.2009.06.014 · Cited by 91
Wasihun, A. G., Welekidan, L. N., Gebremariam, S. A., Dejene, T. A., Luel, A., Haile, T. D., & Saravanan, M. (2015) · SpringerPlus · doi:10.1186/s40064-015-1056-x · Cited by 91
El‐Chami, M. F., Soejima, K., Piccini, J. P., REYNOLDS, D. W., Ritter, P., Okabe, T., Friedman, P. A., Cha, Y., Stromberg, K. D., Holbrook, R., et al. (2019) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13752 · Cited by 91
Intravascular catheter-related infections in an Indian tertiary care hospital
Parameswaran, R., Sherchan, J. B., Muralidhar Varma, D., Mukhopadhyay, C., & Vidyasagar, S. (2010) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.1261 · Cited by 91
“[24] showed that the commonest isolates were CONS (31%) and S.”
BackgroundWhang, D. W., Miller, L. G., Partain, N. M., & McKinnell, J. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00714-13 · Cited by 95
Lalani, T., Kanafani, Z. A., Chu, V. H. Y., Moore, L., Corey, G. R., Pappas, P. A., Woods, C. W., Cabell, C. H., Hoen, B., Selton‐Suty, C., et al. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0141-z · Cited by 106
“amongst outpatients receiving home healthcare [17].”
Nickerson, E. K., Hongsuwan, M., Limmathurotsakul, D., Wuthiekanun, V., Shah, K. R., Srisomang, P., Mahavanakul, W., Wacharaprechasgul, T., Fowler, V. G., West, T. E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004308 · Cited by 91
“The published literature on invasive Staphylococcus aureus disease is heavily skewed towards industrialised temperate countries, where it represents a major cause of community- and hospitalacquired infection [1,2].”
BackgroundRoimi, M., Neuberger, A., Shrot, A., Paul, M., Geffen, Y., & Bar-Lavie, Y. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05876-8 · Cited by 91
The Empirical Combination of Vancomycin and a -Lactam for Staphylococcal Bacteremia
McConeghy, K. W., Bleasdale, S. C., & Rodvold, K. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit560 · Cited by 90
“MRSA in the United States is endemic in the community and hospital setting.”
InfluentialTime to blood culture positivity as a marker for catheter-related candidemia
Ben-Ami, R., Weinberger, M., Orni-Wasserlauff, R., Schwartz, D., Itzhaki, A., Lazarovitch, T., Bash, E., Aharoni, Y., Moroz, I., & Giladi, M. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00214-08 · Cited by 90
“are common causes of nosocomial bloodstream infections, ranking as the fourth most frequent pathogens involved in such infections overall and the third most frequent pathogens in intensive care units (7, 15, 18).”
BackgroundMarra, A. R., Cal, R. G. R., Durão, M. S., Corrêa, L., Guastelli, L. R., Moura, D. F., Edmond, M. B., & dos Santos, O. F. P. (2010) · American Journal of Infection Control · doi:10.1016/j.ajic.2009.11.012 · Cited by 90
Self-citationLoonen, A. J. M., Bos, M. P., Meerbergen, B. V., Neerken, S., Catsburg, A., Dobbelaer, I., Penterman, R., Maertens, G. G., van de Wiel, P. A., Savelkoul, P. H. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072349 · Cited by 94
“Bloodstream infections (BSI) can be caused by a wide variety of pathogens and remain a significant cause of morbidity and mortality especially in the Intensive Care Unit [1,2,3].”
Lee, Y.-C., Huang, Y., Tan, C., Kuo, Y.-W., Liao, C., Lee, P., & Hsueh, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr200 · Cited by 90
An Organ System-Based Synopsis of Pseudomonas aeruginosa Virulence
Morin, C. D., Déziel, É., Gauthier, J., Lévesque, R. C., & Lau, G. W. (2021) · Virulence · doi:10.1080/21505594.2021.1926408 · Cited by 112
“for approximately 4% total cases of hospitalacquired bloodstream infections, and was the third leading cause among Gram-negative pathogens [5].”
BackgroundLu, Y., Chen, Y.-Q., Guo, Y.-L., Qin, S.-M., Wu, C., & Wang, K. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.6175 · Cited by 90
“Search terms included “invasive fungal disease,” “IFD,” “invasive fungal infection,” “IFI,” “deep mycotic infection,” “invasive mycoses,” “invasive mycosis,” “(1-3)-β-D-Glucan,” “β-D-Glucan,” “β-Glucan,” “D-Glucan,” “BG,” and “BDG.” The syntax for the MEDLINE searches was as follows: (“invasive fungal disease” OR “inv…”
Attributable Mortality of Nosocomial Acinetobacter Bacteremia
Grupper, M., Sprecher, H., Mashiach, T., & Finkelstein, R. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/512629 · Cited by 107
Enfermedades Infecciosas y Microbiología Clínica
Viasus, D., Antón, A., Pumarola, T., & Carratalà, J. (2016) · Cited by 90
Wasi, M., Khandelwal, N. K., Moorhouse, A. J., Nair, R., Vishwakarma, P., Bravo Ruiz, G., Ross, Z. K., Lorenz, A., Rudramurthy, S. M., Chakrabarti, A., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01445 · Cited by 89
Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies
Polvi, E. J., Li, X., O’Meara, T. R., Leach, M. D., & Cowen, L. E. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1860-z · Cited by 106
“quired bloodstream infections, and the incidence of Candida infections is increasing [41].”
BackgroundDaptomycin: The role of high-dose and combination therapy for Gram-positive infections
Gould, I. M., Miró, J. M., & Rybak, M. J. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.05.005 · Cited by 93
Antifungal drug resistance: do molecular methods provide a way forward?
Perlin, D. S. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283321ce5 · Cited by 89
“Candidemia is the fourth leading cause of bloodstream infections and carries a 35–55% mortality [ 2 ].”
BackgroundTreatment options of invasive fungal infections in adults
Marchetti, O., Eggimann, P., Pittet, D., Glauser, M., & Calandra, T. (2006) · Swiss Medical Weekly · doi:10.4414/smw.2006.11392 · Cited by 90
Improving on nature: antibiotics that target the ribosome
Sutcliffe, J. A. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.08.004 · Cited by 104
Lin, J., Oh, S.-H., Jones, R., Garnett, J. A., Salgado, P. S., Rusnakova, S., Matthews, S. J., Hoyer, L. L., & Cota, E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.547877 · Cited by 91
Flocculation protein structure and cell–cell adhesion mechanism in Saccharomyces cerevisiae
Goossens, K. V. Y., & Willaert, R. (2010) · Biotechnology Letters · doi:10.1007/s10529-010-0352-3 · Cited by 102
“It is often used as a model to study biofilm formation of pathogenic yeasts, responsible for 41% of the mortality rate in hospitals (Wisplinghoff et al. 2004).”
BackgroundContinuous passive disinfection of catheter hubs prevents contamination and bloodstream infection
Wright, M., Tropp, J., Schora, D. M., Dillon-Grant, M., Peterson, K. E., Boehm, S., Robicsek, A. A., & Peterson, L. R. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2012.05.030 · Cited by 89
Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA ERA
Livorsi, D. J., Daver, N. G., Atmar, R. L., Shelburne, S. A., White, A. C., & Musher, D. M. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.04.012 · Cited by 89
Machado, A. B. M. P., Reiter, K. C., Paiva, R. M., & Barth, A. L. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47294-0 · Cited by 111
“In fact, meticillin-resistant Staphylococcus strains are a common cause of nosocomial infections worldwide (Wisplinghoff et al., 2004; Favre et al., 2005).”
BackgroundMicrobiome mediation of infections in the cancer setting
Taur, Y., & Pamer, E. G. (2016) · Genome Medicine · doi:10.1186/s13073-016-0306-z · Cited by 89
“This contrasts sharply with general hospitals, where Staphylococcus aureus is more typically the most common pathogen encountered, which preferably colonizes skin [3].”
ResultSupplement: Trends in invasive Candida infections and their treatment: focus on echinocandins
(2009) · Current Medical Research and Opinion · doi:10.1185/03007990902990817 · Cited by 89
Streptococcus gordonii comCDE (competence) operon modulates biofilm formation with Candida albicans
Jack, A. A., Daniels, D. E., Jepson, M. A., Vickerman, M. M., Lamont, R. J., Jenkinson, H. F., & Nobbs, A. H. (2015) · Microbiology · doi:10.1099/mic.0.000010 · Cited by 88
“This work was supported by the National Institutes of Health (NIDCR), Bethesda, USA (grant no.”
BackgroundInfluentialSpec, A., Pullman, J., Thompson, G. R., Powderly, W. G., Tobin, E. H., Vazquez, J., Wring, S. A., Angulo, D., Helou, S., Pappas, P. G., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz277 · Cited by 88
Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal Infections
Casapao, A. M., Kullar, R., Davis, S. L., Levine, D. P., Zhao, J. J., Potoski, B. A., Goff, D. A., Crank, C. W., Segreti, J., Sakoulas, G., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00526-13 · Cited by 95
“are the second most common nosocomial bloodstream pathogens isolated in the United States (4), with VRE frequencies in intensive care units (ICU) exceeding 30% (5).”
BackgroundStaphylococcus aureus Pneumonia in the Community
He, H., & Wunderink, R. G. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1709992 · Cited by 81
Gómez-Gaviria, M., & Mora-Montes, H. M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s247944 · Cited by 110
Askarian, F., Uchiyama, S., Masson, H., Sørensen, H. V., Golten, O., Bunæs, A. C., Mekasha, S., Røhr, Å. K., Kommedal, E., Ludviksen, J. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21473-0 · Cited by 93
Pannanusorn, S., Fernandez, V., & Römling, U. (2012) · Mycoses · doi:10.1111/myc.12014 · Cited by 110
Jeong, I. S., Park, S. M., Lee, J. M., Song, J. Y., & Lee, S. J. (2013) · American Journal of Infection Control · doi:10.1016/j.ajic.2012.10.010 · Cited by 88
Merayo‐Chalico, J., Gómez‐Martín, D., Menendez, A., Anda, K. S.-D., & Alcocer-Varela, J. C. (2013) · QJM · doi:10.1093/qjmed/hct046 · Cited by 93
Kaloriti, D., Jacobsen, M., Yin, Z., Patterson, M., Tillmann, A., Smith, D. A., Cook, E., You, T., Grimm, M. J., Bohovych, I., et al. (2014) · mBio · doi:10.1128/mbio.01334-14 · Cited by 88
Drug resistance mechanisms and their regulation in non-albicans Candida species
Kołaczkowska, A., & Kołaczkowski, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv445 · Cited by 87
A combination approach to treating fungal infections
Shrestha, S. K., Fosso, M. Y., & Garneau‐Tsodikova, S. (2015) · Scientific Reports · doi:10.1038/srep17070 · Cited by 96
Banerjee, M., Uppuluri, P., Zhao, X. R., Carlisle, P. L., Vipulanandan, G., Villar, C. C., López-Ribot, J. L., & Kadosh, D. (2013) · Eukaryotic Cell · doi:10.1128/ec.00163-12 · Cited by 88
Luzzaro, F., Ortisi, G., Larosa, M., Drago, M., Brigante, G., & Gesu, G. P. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.10.016 · Cited by 101
“At the same time, Candida species isolated from blood cultures increased from 8% in 1995 to 12% in 2002 (Wisplinghoff et al., 2004).”
BackgroundResultInfluentialStrength in numbers: antifungal strategies against fungal biofilms
Ramage, G., Robertson, S. N., & Williams, C. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.10.023 · Cited by 103
“are so important in the hospital setting and why they are reported as the fourth most common bloodstream infection [48].”
BackgroundLe, H. T., Tran, V. G., Kim, W., Kim, J., Cho, H. R., & Kwon, B. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103564 · Cited by 104
“albicans infection is associated with high mortality in immunocompromised patients receiving anti-cancer therapies or immunosuppressants (49, 50).”
BackgroundWarn, P. A., Sharp, A., Parmar, A., Majithiya, J., Denning, D. W., & Hope, W. W. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01601-08 · Cited by 86
“Candida spp. are consistently the fourth most common cause of bloodstream infections in the United States (21).”
BackgroundHemizygosity Enables a Mutational Transition Governing Fungal Virulence and Commensalism
Liang, S.-H., Anderson, M. Z., Hirakawa, M. P., Wang, J. M., Frazer, C., Alaalm, L. M., Thomson, G. J., Ene, I. V., & Bennett, R. J. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.005 · Cited by 89
Palavecino, E. L. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-468-1_1 · Cited by 107
Metadata
- Authors
- Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B.
- Affiliations
- University of Cologne (DE)
- Virginia Commonwealth University (US)
- Corresponding author
- Edmond, M. B.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08-01
- Volume
- 39
- Issue
- 3
- Pages
- 309-317
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2171155970
- Cited by
- 4,496
- References
- 42
- Citations by year
- 2026: 78 · 2025: 138 · 2024: 137 · 2023: 171 · 2022: 209 · 2021: 187 · 2020: 229 · 2019: 252 · 2018: 215 · 2017: 238 · 2016: 255 · 2015: 271 · 2014: 291 · 2013: 257 · 2012: 241
- FWCI
- 105.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- nosocomial bloodstream infection, nosocomial infections, antibiotic resistance, methicillin-resistant Staphylococcus aureus, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, coagulase-negative staphylococci, candidiasis, intensive care unit, neutropenic patients, infectious disease epidemiology, temporal trends
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Candidiasis, Child, Child, Preschool, Cross Infection, Drug Resistance, Microbial, Female, Humans, Infant, Male, Middle Aged, Population Surveillance, Prospective Studies, Staphylococcal Infections, United States, Causality, Incidence, Fungemia, Bacteremia, Gram-Negative Bacterial Infections, Gram-Positive Bacterial Infections, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.